Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy

BACKGROUND: Cancer cachexia (CCx) is a multifactorial wasting disorder characterized by involuntary loss of body weight that affects many cancer patients and implies a poor prognosis, reducing both tolerance to and efficiency of anticancer therapies. Actual challenges in management of CCx remain in...

Descripción completa

Detalles Bibliográficos
Autores principales: Morigny, Pauline, Kaltenecker, Doris, Zuber, Julia, Machado, Juliano, Mehr, Lisa, Tsokanos, Foivos‐Filippos, Kuzi, Hanna, Hermann, Chris D., Voelkl, Michael, Monogarov, German, Springfeld, Christoph, Laurent, Victor, Engelmann, Bernd, Friess, Helmut, Zörnig, Inka, Krüger, Achim, Krijgsveld, Jeroen, Prokopchuk, Olga, Fisker Schmidt, Søren, Rohm, Maria, Herzig, Stephan, Berriel Diaz, Mauricio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517355/
https://www.ncbi.nlm.nih.gov/pubmed/34427055
http://dx.doi.org/10.1002/jcsm.12758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517355/
https://www.ncbi.nlm.nih.gov/pubmed/34427055
http://dx.doi.org/10.1002/jcsm.12758

Ejemplares similares